Acoustic Neuromas: General Considerations

  • Ihsan Dogan
  • Burak Ozaydin
  • Joseph P. Roche
  • Mustafa K. BaskayaEmail author


VS account for approximately 6–8% of intracranial tumors in adults and are the most common tumor in the CPA ranging between 80% and 95%. Vestibular schwannomas constitute 6% of all intracranial neoplasms and are the most common benign lesions of the IAC and CPA cistern constituting between 60% and 90% of the entire lesions seen in this area. Growth rates in tumors that exhibit enlargement have been reported to be about 1–2 mm per year in linear growth in at least one dimension. While no formal consensus exists, most authors define normal growth rates as being between 1 and 2 mm per year and fast growth rates as 4 mm or greater per year. When considering common presenting manifestations, a helpful framework is to consider manifestations based on the size of the tumor, and its location; intracanalicular, cisternal, brainstem compressive, or hydrocephalic sizes. While any configuration is possible, hearing loss associated with vestibular schwannomas of this size is typically unilateral, progressive, and commonly affects high-frequency thresholds and speech perception. An occipital headache attributable to the tumor is a late finding with 20% of patients with tumors between 1 and 3 cm, with 40% of patients with tumors larger than 3 cm verifying this symptom. Gross total resection is the goal of surgery while maintaining good facial function, in all sizes of tumors, and hearing preservation, in small to moderate size tumors in patients with serviceable preoperative hearing status.


Vestibular schwannoma Acoustic neuroma Cerebellopontine angle Retrosigmoid approach Translabyrinthine approach Middle fossa approach Internal acoustic canal 


  1. 1.
    Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2008;122(2):128–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Angelika Z, et al. Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy. Int J Cancer. 2001;96(6):356–62.CrossRefGoogle Scholar
  3. 3.
    Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol. 2017;38(11):2034–43.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Mahaley MS Jr, et al. Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS. Clin Neurosurg. 1990;36:347–52.PubMedGoogle Scholar
  5. 5.
    Horváth M, et al. Tumors of the cerebellopontine angle. Changing policy in treatment. Neurosurg Rev. 1996;19(4):243–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Betka J, et al. Complications of microsurgery of vestibular schwannoma. Biomed Res Int. 2014;2014:315952.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Moffat DA, Ballagh RH. Rare tumours of the cerebellopontine angle. Clin Oncol. 1995;7(1):28–41.CrossRefGoogle Scholar
  8. 8.
    Springborg JB, Poulsgaard L, Thomsen J. Nonvestibular schwannoma tumors in the cerebellopontine angle: a structured approach and management guidelines. Skull Base. 2008;18(4):217–27.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Hasegawa M, et al. Cerebellopontine angle epidermoid cysts: clinical presentations and surgical outcome. Neurosurg Rev. 2016;39(2):259–66. discussion 266–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Ramsden RT. The bloody angle: 100 years of acoustic neuroma surgery. J R Soc Med. 1995;88(8):464P–8P.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Cushing H. Tumors of the nervus acusticus and the syndrome of the cerebellopontine angle. Philadelphia: Saunders; 1917.Google Scholar
  12. 12.
    Brackmann DE. Vestibular schwannoma (acoustic neuroma). Otolaryngol Clin N Am. 2012;45(2):xiii–xv.CrossRefGoogle Scholar
  13. 13.
    Pellet W. History of vestibular schwannoma surgery. Prog Neurol Surg. 2008;21:6–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Koerbel A, et al. Evolution of vestibular schwannoma surgery: the long journey to current success. Neurosurg Focus. 2005;18(4):e10.PubMedGoogle Scholar
  15. 15.
    Alfaifi A, et al. The top 50 most-cited articles on acoustic neuroma. World Neurosurg. 2018;111:e454–64.PubMedCrossRefGoogle Scholar
  16. 16.
    Dandy WE. Removal of cerebellopontile (acoustic) tumors through a unilateral approach. Arch Surg. 1934;29(3):337–44.CrossRefGoogle Scholar
  17. 17.
    Horrax G, Poppen JL, Strain RE. Results of present day operations for acoustic tumors. Lahey Clin Bull. 1949;6(4):109–11.PubMedGoogle Scholar
  18. 18.
    House WF. Transtemporal bone microsurgical removal of acoustic neuromas. evolution of transtemporal bone removal of acoustic tumors. Arch Otolaryngol. 1964;80:731–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Hitselberger WE, House WF. Surgical approaches to acoustic tumors. Arch Otolaryngol. 1966;84(3):286–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg (1979). 1980;88(5):555–9.CrossRefGoogle Scholar
  21. 21.
    Marcel Maya M, Lo WWM, Kovanlikaya I. Temporal bone: tumor and cerebellopontine angle lesions. In: Som PM, Curtin HD, editors. Head and neck imaging. St. Louis, MO: Mosby; 2003.Google Scholar
  22. 22.
    Propp JM, et al. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology. 2006;8(1):1–11.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Lee A, Chao S, Murphy E. Acoustic neuroma. Appl Radiat Oncol. 2013;2(1):24–6.Google Scholar
  24. 24.
    Evans DGR, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child. 1999;81(6):496–9.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Howitz MF, et al. Incidence of vestibular schwannoma in Denmark, 1977-1995. Am J Otol. 2000;21(5):690–4.PubMedGoogle Scholar
  26. 26.
    Nestor JJ, et al. The incidence of acoustic neuromas. Arch Otolaryngol Head Neck Surg. 1988;114(6):680.PubMedCrossRefGoogle Scholar
  27. 27.
    Tos M, et al. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg. 2004;130(2):216–20.PubMedCrossRefGoogle Scholar
  28. 28.
    Abele TA, et al. Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions. AJNR Am J Neuroradiol. 2014;35(12):2366–70.PubMedCrossRefGoogle Scholar
  29. 29.
    Liudahl AA, et al. Diagnosis of small vestibular schwannomas using constructive interference steady state sequence. Laryngoscope. 2018. Scholar
  30. 30.
    Anderson TD, et al. Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging. Otolaryngol Head Neck Surg. 2000;122(5):643–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Lin D, et al. The prevalence of “incidental” acoustic neuroma. Arch Otolaryngol Head Neck Surg. 2005;131(3):241–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin N Am. 2012;45(2):257–68, vii.PubMedCrossRefGoogle Scholar
  33. 33.
    M, H. and C. SJ. Early asymptomatic acoustic tumor. Report of six cases. Arch Surg. 1936;32:292–301.CrossRefGoogle Scholar
  34. 34.
    Leonard JR, Talbot ML. Asymptomatic acoustic neurilemoma. Arch Otolaryngol. 1970;91(2):117–24.PubMedCrossRefGoogle Scholar
  35. 35.
    Stangerup SE, et al. True incidence of vestibular schwannoma? Neurosurgery. 2010;67(5):1335–40. discussion 1340.PubMedCrossRefGoogle Scholar
  36. 36.
    Lee KS, et al. The proliferative activity of neurilemomas. Surg Neurol. 1989;32(6):427–33.PubMedCrossRefGoogle Scholar
  37. 37.
    Lesser TH, et al. Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67. Skull Base Surg. 1991;1(1):11–5.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Bederson JB, et al. Conservative treatment of patients with acoustic tumors. Neurosurgery. 1991;28(5):646–50. discussion 650–1.Google Scholar
  39. 39.
    Kesterson L, et al. Clinical behavior of acoustic tumors. A flow cytometric analysis. Arch Otolaryngol Head Neck Surg. 1993;119(3):269–71.PubMedCrossRefGoogle Scholar
  40. 40.
    Pasquier B, et al. Evaluation of the acoustic neuroma growth rate by immunohistochemical techniques. In: Tos M, Thomsen J, editors. Proceeding of the first international conference on acoustic neuroma, Amsterdam; 1992. p. 173–6.Google Scholar
  41. 41.
    Nedzelski JM, et al. Conservative management of acoustic neuromas. Otolaryngol Clin N Am. 1992;25(3):691–705.Google Scholar
  42. 42.
    Selesnick SH, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol. 1998;19(6):846–9.PubMedGoogle Scholar
  43. 43.
    Battaglia A, Mastrodimos B, Cueva R. Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol. 2006;27(5):705–12.PubMedCrossRefGoogle Scholar
  44. 44.
    Mirz F, et al. Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977-98. Acta Otolaryngol Suppl. 2000;543:30–3.PubMedGoogle Scholar
  45. 45.
    Shin YJ, et al. Effectiveness of conservative management of acoustic neuromas. Am J Otol. 2000;21(6):857–62.PubMedGoogle Scholar
  46. 46.
    Hoistad DL, et al. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22(5):682–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Tschudi DC, Linder TE, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol. 2000;21(5):722–8.PubMedGoogle Scholar
  48. 48.
    Strasnick B, et al. The natural history of untreated acoustic neuromas. Laryngoscope. 1994;104(9):1115–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Bakkouri WE, et al. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg. 2009;110(4):662–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Baser M, et al. Evaluation of genotype-phenotype correlations for vestibular schwannoma growth rates in neurofibromatosis 2. In: Fourth international conference on vestibular schwannoma and other CPA lesions, Cambridge, England; 2003.Google Scholar
  51. 51.
    Lanser M, Jackler R, Pitts L. Intratumoral hemorrhage and cyst expansion as causes of acute neurological deterioration in acoustic neuroma patients. In:Proceeding of the first international conference on acoustic neuroma. Amsterdam: Kugler; 1992.Google Scholar
  52. 52.
    Stangerup SE, et al. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27(4):547–52.PubMedGoogle Scholar
  53. 53.
    Hunter JB, et al. Single institutional experience with observing 564 vestibular schwannomas: factors associated with tumor growth. Otol Neurotol. 2016;37(10):1630–6.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Stangerup SE, et al. Change in hearing during ‘wait and scan’ management of patients with vestibular schwannoma. J Laryngol Otol. 2008;122(7):673–81.PubMedCrossRefGoogle Scholar
  55. 55.
    Stangerup SE, et al. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31(2):271–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Stangerup SE, et al. Hearing outcomes of vestibular schwannoma patients managed with ‘wait and scan’: predictive value of hearing level at diagnosis. J Laryngol Otol. 2010;124(5):490–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Elliott A, et al. Hearing preservation in vestibular schwannoma management. Am J Otolaryngol. 2015;36(4):526–34.PubMedCrossRefGoogle Scholar
  58. 58.
    Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9–10.PubMedGoogle Scholar
  59. 59.
    Harner SG, Fabry DA, Beatty CW. Audiometric findings in patients with acoustic neuroma. Am J Otol. 2000;21(3):405–11.PubMedCrossRefGoogle Scholar
  60. 60.
    Thomsen J, Tos M. Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol. 1990;11(1):12–9.PubMedGoogle Scholar
  61. 61.
    Selesnick SH, Jackler RK. Atypical hearing loss in acoustic neuroma patients. Laryngoscope. 1993;103(4 Pt 1):437–41.PubMedCrossRefGoogle Scholar
  62. 62.
    Edwards CH, Paterson JH. A review of the symptoms and signs of acoustic neurofibromata. Brain. 1951;74(2):144–90.PubMedCrossRefGoogle Scholar
  63. 63.
    Simon C, Brichet B, Decroocq F. An electromyographic study of the facial nerve and its innervation territy by detection, stimulo-detection, and blink reflex in preoperative acoustic neuroma. In:Proceeding of the First International Conference on Acoustic Neuroma. Amsterdam: Kugler; 1992.Google Scholar
  64. 64.
    Zubay G, Porter RW, Spetzler RF. Neurofibromatosis. Oper Tech Neurosurg. 2001;4(1):43–6.CrossRefGoogle Scholar
  65. 65.
    Rouleau GA, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363:515.PubMedCrossRefGoogle Scholar
  66. 66.
    Obremski VJ, Hall AM, Fernandez‐Valle C. Merlin, the neurofibromatosis type 2 gene product, and β1 integrin associate in isolated and differentiating Schwann cells. J Neurobiol. 1998;37(4):487–501.PubMedCrossRefGoogle Scholar
  67. 67.
    Prasad SC, et al. Decision making in the wait-and-scan approach for vestibular schwannomas: is there a price to pay in terms of hearing, facial nerve, and overall outcomes? Neurosurgery. 2017. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ihsan Dogan
    • 1
  • Burak Ozaydin
    • 1
  • Joseph P. Roche
    • 2
  • Mustafa K. Baskaya
    • 1
  1. 1.Department of Neurological SurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, Section of Otology/NeurotologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations